Comparison

Roquinimex

Item no. V4039-10mg
Manufacturer InvivoChem LLC
CASRN 84088-42-6
Amount 10 mg
Quantity options 100 mg 250 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V4039CAS #:84088-42-6Purity >=98%

Description: Roquinimex (also known as LS 2616 and FCF89; trade name: Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity. It also inhibits angiogenesis and reduces the secretion of TNF alpha. Roquinimex has been investigated as a treatment for some cancers (including as adjuvant therapy after bone marrow transplantation in acute leukemia) and autoimmune diseases, such as multiple sclerosis and recent-onset type I diabetes. Several trials have been terminated due to serious cardiovascular toxicity.

Description:

References: 2003 Feb; 52(2):64-8; 1998 Aug; 98(2):94-101.

References:


Molecular Weight (MW)
308.33
Formula
C18H16N2O3
CAS No.
84088-42-6
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: >= 80mg/mL
Water: N/A
Ethanol: N/A
Chemical Name
4-hydroxy-N, 1-dimethyl-2-oxo-N-phenyl-1, 2-dihydroquinoline-3-carboxamide
Synonyms
LS2616; LS2616; LS 2616; FCF89; FCF89; FCF 89; Linomide. Trade name: Linomide
SMILES Code
O=C(C1=C(O)C2=C(N(C)C1=O)C=CC=C2)N(C)C3=CC=CC=C3

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close